1. Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol 2003;38(Suppl 1):S38-S53. 12591185.
3. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500. 11172192.
4. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139:667-669. 443970.
5. Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 2003;67:138-145. 12853725.
6. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457. 14647056.
7. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075. 11297957.
8. Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the fibrotest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003;49:450-454. 12600957.
9. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003;38:481-492. 12883493.
10. Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, et al. The predictive value of fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 2004;39:862-863 author reply 863. 14999708.
11. Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, et al. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003;37:1220-1221 author reply 1221. 12717403.
12. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-992. 12297848.
13. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526. 12883497.
14. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282-292. 15986415.
15. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004;99:271-279. 15046217.
16. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-230. 12873819.
17. Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, et al. Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci 2011;56:555-563. 20585981.
19. Tirnitz-Parker JE, Glanfield A, Olynyk JK, Ramm GA. Iron and hepatic carcinogenesis. Crit Rev Oncog 2013;18:391-407. 23879586.
20. Vagu C, Sultana C, Ruta S. Serum iron markers in patients with chronic hepatitis C infection. Hepat Mon 2013;13:e13136. 24348638.
21. Fletcher LM, Halliday JW, Powell LW. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol 1999;14:202-214. 10197487.
22. Xu MY, Qu Y, Jia XF, Wang ML, Liu H, Wang XP, et al. Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B. Biomed Pharmacother 2013;67:561-567. 23639231.
26. Kohnlein T, Rifai K. [Alpha1-antitrypsin deficiency]. Internist (Berl) 2010;51(Suppl 1):269-276. 20135085.
27. Beloborodova EV, Beloborodova EI, Akbasheva OE, Serebrov VIu, Chernogoriuk GE, Rachkovskiĭ MI, et al. [The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies]. Ter Arkh 2010;82:29-34. 20387672.
28. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2004;99:286-291. 15046219.
29. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850. 11473047.
30. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-29. 3943787.
31. Fletcher LM. Alcohol and iron: one glass of red or more. J Gastroenterol Hepatol 1996;11:1039-1041. 8985826.
33. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995. 10607817.
34. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;190:1-46. 2208733.
35. Potter BJ, Chapman RW, Nunes RM, Sorrentino D, Sherlock S. Transferrin metabolism in alcoholic liver disease. Hepatology 1985;5:714-721. 4029886.
36. Ibrahim AM, Ali MM, Ghanem HM, Mousa AM, Ghafar TYA. Simple and rapid detection of liver cirrhosis in children by tracking serum IgA/transferrin ratio. J Exp Integr Med 2011;1:117-121.
38. Hino K, Nishina S, Hara Y. Iron metabolic disorder in chronic hepatitis C: Mechanisms and relevance to hepatocarcinogenesis. J Gastroenterol Hepatol 2013;28:93-98. 24251712.
39. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983;52:655-709. 6193754.
40. Dickson I, Alper CA. Changes in serum proteinase inhibitor levels following bone surgery. Clin Chim Acta 1974;54:381-385. 4547155.
41. Cho HJ, Kim SS, Ahn SJ, Bae CB, Kim HG, Kim YJ, et al. Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem 2012;45:1564-1567. 22885475.
42. Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-623. 15743360.